MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
T2 Biosystems EBITDA per Share 2011-2026 | TTOO
Annual EBITDA per Share T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.7 | -1.06 K | -13.1 | -0.268 | -1.06 | -1.05 | -1.58 | -1.87 | -2.04 | -3.46 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.268 | -1.06 K | -110 |
Quarterly EBITDA per Share T2 Biosystems
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.56 | -0.67 | -2.46 | - | -3.02 | -16 | -98.5 | - | -2.58 | -4.19 | -4.29 | - | -3.59 | -0.07 | -0.06 | - | -0.07 | -0.07 | -0.19 | -0.24 | -0.26 | -0.3 | -0.29 | -0.31 | -0.2 | -0.27 | -0.3 | -0.4 | -0.33 | -0.41 | -0.41 | -0.42 | -0.41 | -0.5 | -0.5 | -0.48 | -0.5 | -0.49 | -0.49 | -0.44 | -0.59 | -4.72 | -4.79 | -3.99 | -2.93 | -3.31 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.06 | -98.5 | -3.92 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 168.22 | -3.26 % | $ 8.34 B |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 114.84 | -0.55 % | $ 34.9 B | USA |
 |
Castle Biosciences
CSTL
|
0.89 | $ 24.73 | -0.44 % | $ 687 M | USA |
 |
Danaher Corporation
DHR
|
7.63 | $ 192.12 | 0.53 % | $ 137 B | USA |
 |
DexCom
DXCM
|
2.98 | $ 63.21 | 1.59 % | $ 24.7 B | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
-1.62 | $ 16.42 | -2.38 % | $ 496 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M |  Israel |
 |
Guardant Health
GH
|
-3.17 | $ 89.66 | -4.44 % | $ 11.2 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 109.62 | -4.0 % | $ 9.04 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 17.82 | -2.68 % | $ 950 M | USA |
 |
Illumina
ILMN
|
-3.01 | $ 127.74 | 0.28 % | $ 20.3 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 16.3 | 0.62 % | $ 175 M |  China |
 |
IQVIA Holdings
IQV
|
19.4 | $ 170.72 | -1.47 % | $ 29.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 274.46 | 0.27 % | $ 22.8 B | USA |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 75.89 | -0.28 % | $ 5.12 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 496.0 | -0.47 % | $ 14.3 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 266.63 | 0.53 % | $ 26.1 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 4.67 | -1.68 % | $ 432 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-7.27 | $ 4.74 | 1.07 % | $ 3.73 M | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 8.02 | 0.25 % | $ 1.03 B | USA |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.56 | 1.59 % | $ 2.07 B | USA |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 17.33 | 0.99 % | $ 388 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 204.87 | -1.5 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
-0.22 | $ 15.36 | 1.92 % | $ 1.99 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
-1.8 | $ 1.42 | 5.97 % | $ 426 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.61 | $ 27.2 | 0.33 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
0.03 | $ 25.98 | 1.64 % | $ 41.7 M | USA |
 |
Personalis
PSNL
|
-0.97 | $ 6.58 | - | $ 390 M | USA |
 |
RadNet
RDNT
|
2.85 | $ 55.06 | 0.49 % | $ 4.14 B | USA |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.69 | -3.04 % | $ 279 M | USA |
 |
Sotera Health Company
SHC
|
0.33 | $ 14.87 | -0.6 % | $ 4.22 B | USA |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Soleno Therapeutics
SLNO
|
0.22 | $ 52.25 | 32.31 % | $ 2.66 B | USA |
 |
Neuronetics
STIM
|
-0.42 | $ 1.76 | 15.79 % | $ 116 M | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 488.19 | -0.67 % | $ 184 B | USA |